CyMedica e-vive
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $80,209 | 3 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $80,209 | 3 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CM-2019 A randomized, sham controlled, double-blind, multi-center study of Neuromuscular Electrical Stimulation (NMES) as an Adjunctive Therapy for Knee Pain Relief and Improving Functional Outcomes in Knee Osteoarthritis (OA) Patients | CyMedica Orthopedics, Inc. | $63,532 | 0 |
| CM-2019, A randomized, sham controlled, double-blind, multi-center study of Neuromuscular Electrical Stimulation (NMES) as an Adjunctive Therapy for Knee Pain Relief and Improving Functional Outcomes in Knee Osteoarthritis (OA) Patients | CyMedica Orthopedics, Inc. | $12,350 | 1 |
| Lenox Hill Study | CyMedica Orthopedics, Inc. | $4,328 | 0 |
Top Doctors Receiving Payments for CyMedica e-vive
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | New York, NY | $67,859 | 2 |
| , MD | Family Medicine | Tucson, AZ | $12,350 | 1 |
Manufacturing Companies
- CyMedica Orthopedics, Inc. $80,209
Product Information
- Type Device
- Total Payments $80,209
- Total Doctors 1
- Transactions 3
About CyMedica e-vive
CyMedica e-vive is a device associated with $80,209 in payments to 1 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is CyMedica Orthopedics, Inc..
Payment data is available from 2021 to 2021. In 2021, $80,209 was paid across 3 transactions to 1 doctors.
The most common payment nature for CyMedica e-vive is "Unspecified" ($80,209, 100.0% of total).
CyMedica e-vive is associated with 3 research studies, including "CM-2019 A randomized, sham controlled, double-blind, multi-center study of Neuromuscular Electrical Stimulation (NMES) as an Adjunctive Therapy for Knee Pain Relief and Improving Functional Outcomes in Knee Osteoarthritis (OA) Patients" ($63,532).